Bausch Health
BHC
#3383
Rank
HK$26.70 B
Marketcap
HK$72.61
Share price
-0.85%
Change (1 day)
35.95%
Change (1 year)
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.

EPS for Bausch Health (BHC)

EPS in 2023 (TTM): -HK$20.80

According to Bausch Health 's latest financial reports the company's current EPS (TTM) is -HK$20.66. In 2022 the company made an earnings per share (EPS) of -HK$4.83 an increase over its 2021 EPS that were of -HK$20.66.

EPS history for Bausch Health from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$20.80330.81%
2022-HK$4.83-76.64%
2021-HK$20.6668.45%
2020-HK$12.27-68.91%
2019-HK$39.46-57.11%
2018-HK$92.00-272.22%
2017HK$53.42-199.29%
2016-HK$53.80798.7%
2015-HK$5.99-128.31%
2014HK$21.15-204.62%
2013-HK$20.21602.7%
2012-HK$2.88-171.15%
2011HK$4.04-143.96%
2010-HK$9.20-206.57%
2009HK$8.63-11.2%
2008HK$9.722.46%
2007HK$9.48-7.58%
2006HK$10.26-14.29%
2005HK$11.9754%
2004HK$7.77-500%
2003-HK$1.94-141.67%
2002HK$4.66-4.76%
2001HK$4.90-175%
2000-HK$6.53-268%
1999HK$3.8914.94%
1998HK$3.3820.83%
1997HK$2.8053.83%
1996HK$1.82

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-HK$7.77-62.37%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.10-89.84%๐Ÿ‡บ๐Ÿ‡ธ USA